Bénédict G. F. Hentsch
Director/Board Member at University of St. Gallen
Bénédict G. F. Hentsch active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of St. Gallen | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - | |
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Director/Board Member | - | - |
Career history of Bénédict G. F. Hentsch
Former positions of Bénédict G. F. Hentsch
| Companies | Position | Start | End |
|---|---|---|---|
One Swiss Bank SA (Switzerland)
 One Swiss Bank SA (Switzerland) Investment ManagersFinance Part of Sator SpA, One Swiss Bank SA (Switzerland) is a company that provides investment advice. The company is based in Geneva, Switzerland. The company was founded in 2004 by Robert Pennone, Bénédict G. F. Hentsch. Grégoire Pennone has been the CEO of the company since 2015. One Swiss Bank SA (Switzerland was acquired by Banque Profil De Gestion SA on June 01, 2021 for $43.37 million. | Chairman | 2011-09-06 | 2014-01-29 |
| Founder | 2010-07-12 | 2014-01-29 | |
| President | 2003-12-31 | 2011-09-06 | |
Schweizerische Rückversicherungs-Gesellschaft AG
 Schweizerische Rückversicherungs-Gesellschaft AG Insurance Brokers/ServicesFinance Schweizerische Rückversicherungs-Gesellschaft AG provides reinsurance, insurance, and risk management solutions. The firm focuses on the property and casualty, life and health, and asset management sectors. The company was founded on May 1, 1883 and is headquartered in Zurich, Switzerland. | Director/Board Member | 1992-12-31 | 2009-03-12 |
| Corporate Officer/Principal | - | - | |
| Darier Hentsch & Cie | Corporate Officer/Principal | 1984-12-31 | 2000-09-30 |
Fairfield Greenwich Advisors LLC
 Fairfield Greenwich Advisors LLC Investment ManagersFinance Founded in 1983, Fairfield Greenwich Group's (FGG) is a hedge fund manager located in New York City. They have additional offices in New York, London and Bermuda, and representative offices elsewhere in the US, Europe, Latin America and Asia and a joint venture in Singapore. | Director/Board Member | 2008-08-31 | - |
Training of Bénédict G. F. Hentsch
| University of St. Gallen | Undergraduate Degree |
Statistics
International
| Switzerland | 6 |
| United States | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
Sectoral
| Finance | 5 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Schweizerische Rückversicherungs-Gesellschaft AG
Schweizerische Rückversicherungs-Gesellschaft AG Insurance Brokers/ServicesFinance Schweizerische Rückversicherungs-Gesellschaft AG provides reinsurance, insurance, and risk management solutions. The firm focuses on the property and casualty, life and health, and asset management sectors. The company was founded on May 1, 1883 and is headquartered in Zurich, Switzerland. | Finance |
Fairfield Greenwich Advisors LLC
Fairfield Greenwich Advisors LLC Investment ManagersFinance Founded in 1983, Fairfield Greenwich Group's (FGG) is a hedge fund manager located in New York City. They have additional offices in New York, London and Bermuda, and representative offices elsewhere in the US, Europe, Latin America and Asia and a joint venture in Singapore. | Finance |
| Darier Hentsch & Cie | Finance |
One Swiss Bank SA (Switzerland)
One Swiss Bank SA (Switzerland) Investment ManagersFinance Part of Sator SpA, One Swiss Bank SA (Switzerland) is a company that provides investment advice. The company is based in Geneva, Switzerland. The company was founded in 2004 by Robert Pennone, Bénédict G. F. Hentsch. Grégoire Pennone has been the CEO of the company since 2015. One Swiss Bank SA (Switzerland was acquired by Banque Profil De Gestion SA on June 01, 2021 for $43.37 million. | Finance |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
